Concepedia

Mark D. Andrews

MD

22

Publications

914

Citations

15

H-Index

1994

Active since

Affiliations

Pfizer (United Kingdom)(Current)

Pfizer (United States)

University of Oxford

Wake Forest University

University of Alberta

Mark D. Andrews is an author at Pfizer (United Kingdom) specializing in pharmacology, medicine, and drug discovery.

Top concepts

PharmacologyMedicineDrug DiscoveryPharmacotherapyMedicinal ChemistryNatural SciencesChemistryBiochemistryMolecular PharmacologyOrganic Chemistry

Publications per year

1994–2018

22

Publications

22

Common tinea infections in children.

Mark D. Andrews, Marianthe Burns · PubMed · 2008 · 119 citations

Ophthalmology, Common Tinea Infections, Antifungal Agents +13

Cryosurgery for common skin conditions.

Mark D. Andrews · PubMed · 2004 · 115 citations

Light Skin, Gross Anatomy, Common Skin Conditions +9

Inhibition of TRPM8 Channels Reduces Pain in the Cold Pressor Test in Humans

Wendy J. Winchester, Katrina Gore, Sophie Glatt et al. · Journal of Pharmacology and Experimental Therapeutics · 2014 · 90 citations

The Discovery of a Potent, Selective, and Peripherally Restricted Pan-Trk Inhibitor (PF-06273340) for the Treatment of Pain

S. Skerratt, Mark D. Andrews, Sharan K. Bagal et al. · Journal of Medicinal Chemistry · 2016 · 80 citations · Full text

Pain Therapy, Drug Target, Pan-trk Inhibitor +21

Discovery of a Selective TRPM8 Antagonist with Clinical Efficacy in Cold-Related Pain

Mark D. Andrews, Kerry af Forselles, Kevin Beaumont et al. · ACS Medicinal Chemistry Letters · 2015 · 79 citations · Full text

Transient Receptor Potential, Molecular Pain, Thermal Therapy +25

Rows per page

1–5 of 22